Exfoliative dermatitis
☆ AI Dermatology — Free Service
A cikin sakamakon Stiftung Warentest na 2022 daga Jamus, gamsuwar mabukaci tare da ModelDerm ya ɗan yi ƙasa kaɗan fiye da biyan shawarwarin telemedicine.
A cikin sakamakon Stiftung Warentest na 2022 daga Jamus, gamsuwar mabukaci tare da ModelDerm ya ɗan yi ƙasa kaɗan fiye da biyan shawarwarin telemedicine.
Red (burning) Skin Syndrome ― Erythema da ma'auni a jikin duka sune manyan alamun Exfoliative dermatitis.
relevance score : -100.0%
ReferencesErythroderma cuta ce da ba kasafai ake samu ba, amma mai tsanani. Duk da cewa ba a san ainihin abin da ke haifar da shi ba, ana iya haifar da shi ta hanyar maganin chemotherapy ko ciwon daji mai tushe. Ɗaya daga cikin cututtukan daji na yau da kullum da ke hade da dermatitis exfoliative shine T-cell lymphoma, wanda ba zai nuna alamun bayyanar ba har tsawon watanni ko ma shekaru bayan yanayin fata ya fara. Yawancin lokaci, ana buƙatar asibiti don tantancewa da magani na farko. Marasa lafiya da cututtukan da ke haifar da muggan ƙwayoyi gabaɗaya suna da kyakkyawan hangen nesa na dogon lokaci, kodayake lokuta ba tare da bayyananniyar dalili ba suna iya maimaitawa da sake dawowa. Hasashen abubuwan da ke da alaƙa da ciwon daji yawanci ya dogara ne akan yadda ciwon daji ke ci gaba.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
Yawanci yana nuna ja da ƙwanƙwasa wanda ke rufe sama da kashi 90 % na jiki. Wannan yanayin alama ce ta bayyane na al'amuran kiwon lafiya daban‑daban kamar psoriasis, eczema, ko martani ga wasu magunguna.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
Mafi yawan abubuwan da ke haifar da erythroderma su ne ƙara yawan cututtukan fata, irin su psoriasis, lamba dermatitis, seborrheic dermatitis, lichen planus, pityriasis rubra pilaris, ko maganin miyagun ƙwayoyi kamar amfani da kwayoyin steroids. Bayyanar farko ba ta da yawa, kuma yawanci ana gani a lokuta na lymphoma na T‑cell na fata. Domin yana da mahimmanci a bambanta shi da lymphoma na T‑cell, ana yin biopsy.